Attached files
file | filename |
---|---|
EX-10.2 - HUIHENG MEDICAL, INC. | v206164_ex10-2.htm |
EX-32 - HUIHENG MEDICAL, INC. | v206164_ex32.htm |
EX-31.1 - HUIHENG MEDICAL, INC. | v206164_ex31-1.htm |
EX-31.2 - HUIHENG MEDICAL, INC. | v206164_ex31-2.htm |
UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q/A
Amendment
No. 1
(Mark
One)
x QUARTERLY REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
For the
Quarterly Period Ended September 30, 2010
¨ TRANSITION REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
For the
transition period from _____ to _____.
Commission File No.
333-132056
HUIHENG MEDICAL,
INC.
(Exact
Name of Registrant as Specified in Its Charter)
Nevada
|
20-4078899
|
|
(State
or Other Jurisdiction
Of
Incorporation or Organization)
|
(I.R.S.
Employer Identification
Number)
|
|
Huiheng
Building, Gaoxin 7 Street South,
Keyuannan
Road, Nanshan District,
Shenzhen
Guangdong, P.R. China 518057
|
N/A
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code 86-755-25331366
Indicate
by check mark whether the registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports); and (2) has been subject to such filing requirements for
the past 90 days.
Yes
¨ No
x
Indicate
by check mark whether the registrant has submitted electronically and posted on
its corporate Web site, if any, every Interactive Data File required to be
submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this
chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files).
Yes ¨ No
¨
Indicate
by checkmark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer or a smaller reporting company. See
the definitions of “large accelerated filer,” “accelerated filer” and “smaller
reporting company” in Rule 12b-3 of the Exchange Act.
Large
accelerated filer
|
¨
|
Accelerated
filer
|
¨
|
Non-accelerated
filer
|
¨
|
Smaller
reporting company
|
x
|
(Do
not check if a smaller reporting
company)
|
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act).
Yes ¨ No
x
As of
November 15, 2010, there were 13,991,288 shares of the issuer’s $0.001 par value
common stock issued and outstanding.
We are
filing this Amendment No. 1 on Form 10-Q/A (this “Amendment”) solely for the
purpose of submitting a redacted version of appendix 1 and appendix 2 of Exhibit
10.2 and amending the disclosure with respect to such Exhibit 10.2 of our
Quarterly Report on Form 10-Q for the quarter ended September 30, 2010 (the
“Original Filing”), filed with the Securities and Exchange Commission (the
“SEC”) on November 22, 2010. We have submitted a letter to the SEC
requesting confidential treatment of appendix 1 and appendix 2 of Exhibit 10.2
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”) and the Freedom of Information Act (“FOIA”), Exemption 4, 5
U.S.C. §
552(b)(4).
Pursuant
to Rule 12b-15 under the Exchange Act (“Rule 12b-15”), this Amendment contains
the complete text of the information incorporated into Item 6, as
amended. In addition, as required by Rule 12b-15, new certifications
of our principal executive officer and principal financial officer are also
being filed and/or furnished as exhibits to this Amendment.
Except as
described above, we have not modified or updated other disclosures presented in
the Original Filing. This Amendment does not amend, update or change the
financial statements or any other disclosures in the Original Filing and does
not reflect events occurring after the filing of the Original
Filing.
Item
6. Exhibits
The
following exhibits are filed as a part of Amendment No. 1 to this Quarterly
Report.
Exhibit
No
|
Description
|
|
10.2
|
Purchase
Contract of Cobalt-60 Radiation Sources Used in SGS-I with Beijing Atom
High-Tech Co.(1)*
|
|
31.1
|
Certification
by the Chief Executive Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002*
|
|
31.2
|
Certification
by the Chief Financial Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002*
|
|
32.1
|
Certification
by the Chief Executive Officer and Chief Financial Officer pursuant to
Section 906 of the Sarbanes-Oxley Act of
2002*
|
*
|
Filed
herewith
|
(1)
|
Material
has been redacted from this exhibit and filed separately with the SEC
pursuant to a request for confidential treatment pursuant to Rule 24b-2 of
the Exchange Act.
|
2
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned thereunto duly
authorized.
HUIHENG
MEDICAL, INC.
|
||
Date: December
28, 2010
|
By:
|
/s/
Hui Xiaobing
|
Hui
Xiaobing
|
||
Chief
Executive Officer
|
||
(Principal
Executive Officer)
|
||
Date: December
28, 2010
|
By:
|
/s/
Richard Shen
|
Richard
Shen
|
||
Chief
Financial Officer
|
||
(Principal
Accounting and Financial
Officer)
|